Seelos Therapeutics Says The Study Did Not Meet Statistical Significance In The Primary And Secondary Endpoint In The Full Analysis Set
Seelos Therapeutics Says The Study Did Not Meet Statistical Significance In The Primary And Secondary Endpoint In The Full Analysis Set
Seelos Therapeutics表示，該研究在完整分析集的主要和次要終點中未達到統計學意義
Seelos Therapeutics Says The Study Did Not Meet Statistical Significance In The Primary And Secondary Endpoint In The Full Analysis Set
Seelos Therapeutics表示，該研究在完整分析集的主要和次要終點中未達到統計學意義
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。